Shanelle focuses her practice on mergers and acquisitions and other strategic transactions for public and private companies. Leveraging a deep background in securities compliance and capital markets, she helps clients navigate the full lifecycle of their business—from securing financing to executing transformational combinations and exits.
Shanelle advises companies on a wide range of capital raising strategies, including shelf registration statements, at-the-market (ATM) offerings and other equity offerings, as well as reverse mergers and business combinations. She also regularly counsels clients in the life sciences, biotechnology and technology sectors on SEC compliance and corporate governance matters.
Shanelle readily understands the challenges that come with pursuing growth in an environment shaped by evolving disclosure requirements and broader market volatility. Clients value her tactical approach and her fluency in deal dynamics and complex securities regulations. Her prior experience working at a global technology startup as well as a Fortune 100 company gives her first-hand insight into the operational realities of businesses at varying scales. This practical perspective allows her to align her legal counsel with commercial drivers and serve as an extension of her clients’ internal teams.
Prior to joining Benesch, Shanelle was a corporate associate at WilmerHale. In this role, she also served as a producer for the firm’s podcast, “In the Public Interest,” developing episodes on topics including annual M&A forecasts, cryptocurrency regulation and the impact of AI on corporate law.
* Matter completed prior to joining Benesch.
Representative Experience:
- Advised Kalaris Therapeutics on its reverse merger with AlloVir, creating a combined public company focused on retinal treatments. Served on the ongoing public company counsel team post-merger. *
- Advised Ocular Therapeutix, Inc. (Nasdaq: OCUL) in its $475 million underwritten public offering of common stock to fund clinical trials for retinal treatments. *
- Advised TechTarget, Inc. on employment and executive compensation matters related to its $350 million combination with the digital businesses of Informa PLC’s Informa Tech division. Served on the ongoing public company counsel team following the strategic transaction. *